Skip to main content
Fig. 5 | Clinical Epigenetics

Fig. 5

From: Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Fig. 5

Responses, mutation burden changes and survival status of patients harboring BCOR mutations treated with decitabine. Panel a shows the VAF changes from before to after decitabine therapy. Green circles indicated for CR patients and red circles for non-CR patients. Panel b shows the overall survival of BCORMUT and BCORWT patients who received decitabine therapy. In Panel c, the decitabine administration, response and survival status are indicated

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us